谷歌浏览器插件
订阅小程序
在清言上使用

Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 As Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study

ANNALS OF SURGICAL ONCOLOGY(2023)

引用 1|浏览35
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要